Adrenocortical Carcinoma Clinical Trials

64 clinical trials for Adrenocortical Carcinoma across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma — RECRUITING · PHASE1
• PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma — RECRUITING · PHASE2
• Familial Investigations of Childhood Cancer Predisposition — RECRUITING
• German Adrenocortical Carcinoma Registry — RECRUITING
• Adrenal Tumors - Pathogenesis and Therapy — RECRUITING
• Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma — RECRUITING · PHASE2
• Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors — RECRUITING · PHASE1
• Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI — RECRUITING · PHASE2
• Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma — RECRUITING · PHASE2
• Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma. — RECRUITING · PHASE2
• Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC) — RECRUITING · PHASE2
• A Prospective Cohort Study for Patients With Adrenal Diseases — RECRUITING
• Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy — NOT_YET_RECRUITING · PHASE1
• Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• PROSPECTIVE, PHASE II STUDY TO EVALUATE THE EFFICACY OF ADDITION OF PROGESTERONE TO STANDARD CHEMOTHERAPY ACCORDING TO EDP SCHEME PLUS MITOTANE IN PATIENTS WITH ADVANCED ADRENAL CORTICAL CARCINOMA - PESETA TRIAL — TERMINATED · PHASE2
• Evaluation of Side Effects of Mitotane — ACTIVE_NOT_RECRUITING
• Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma — ACTIVE_NOT_RECRUITING
• Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• A multicentre, open-label phase 2 study to evaluate the efficacy and safety of pembrolizumab in the treatment of advanced, progressive adrenocortical carcinoma — TERMINATED · PHASE2
• Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC) — ACTIVE_NOT_RECRUITING
• A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma — TERMINATED · PHASE1
• Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase 1 Study of [225Ac]-FPI-1434 Injection — TERMINATED · PHASE1
• Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield — COMPLETED
• A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma — TERMINATED · PHASE2
• Cemiplimab maintenance treatment for advanced adrenocortical cancer — TERMINATED · PHASE2
• Phase 1 Study of 68Ga-R8760 — TERMINATED · PHASE1
• A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma — COMPLETED · PHASE3
• Milademetan in Advanced/Metastatic Solid Tumors — TERMINATED · PHASE2
• Cabozantinib in Advanced Adrenocortical Carcinoma — OTHER · PHASE2
• Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma — COMPLETED · PHASE3
• Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma — OTHER · PHASE2
• Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol) — COMPLETED · PHASE1
• Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy — OTHER
• The Adverse Event of Mitotane Therapy in Patients With Adrenocortical Carcinoma — OTHER
• European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical Carcinoma — OTHER
• The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma — COMPLETED
• Natural History Study of Children and Adults With Adrenocortical Cancer (ACC) — TERMINATED
• Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical Carcinoma — OTHER
• First-in-human Evaluation of [18F]CETO — COMPLETED · PHASE1
• A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549 — OTHER · PHASE1
• Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma — COMPLETED
• Surgery and Heated Chemotherapy for Adrenocortical Carcinoma — COMPLETED · PHASE2
• Sunitinib in Refractory Adrenocortical Carcinoma — COMPLETED · PHASE2
• A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients — COMPLETED · PHASE1
• Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines — OTHER · PHASE2
• Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma — COMPLETED · PHASE1
• Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma — OTHER · PHASE2
• Efficacy of Adjuvant Mitotane Treatment (ADIUVO) — OTHER · PHASE3

Refine this search